In agriculture, support for post-harvest investments, dairy...
Category:
Health
Latest
Interim Budget: Big infra projects outlay hiked to Rs 11.1 lakh crore, cuts fiscal deficit to 5.1% of GDP
High-powered committee to look into the challenges arising from...
Burman family raises stake in Religare Enterprises to 25%
Mohit Burman, chairman, Dabur India The acquirers of Raligare are...
Central team probing bid flu death in Gurugram: Official
The National Centre for Disease Control (NCDC) has also been requested to provide the details of the case regarding its complete history, progress of case, place and time of first reporting and initial findings so that a detailed investigation can be initiated, the official said.
FAO head urges G20 to invest in a healthy planet for healthy food
“Today, humanity faces a triple planetary crisis of biodiversity loss, climate crisis and the impact of the pandemic.To have healthy food, we need a healthy environment”. said Director-General of the UN Food and Agriculture Organization (FAO), Qu Dongyu
Olympics linked Covid cases go past 100, organisers announce 19 new cases
The total number of cases directly linked to the Games stood at 106 on Friday with 11 of them athletes.
The Tokyo Olympic organisers, in their daily COVID-19 update, announced that three athletes, 10 Games-concerned personnel, three mediapersons and as many contractors associated with the event have been found positive.
Max Bupa Health rebrands to Niva Bupa; aims total business of Rs 2,500 cr in FY22
“Owing to a change in shareholding pattern, with the exit of Max India and entry of private equity firm True North, Max Bupa needed to create a new brand identity as part of the transition,” the company said in a statement.
67.6 per cent population above 6 years found to have Covid antibodies in 4th national serosurvey, Lok Sabha told
Metropolitan cities such as Delhi, Mumbai, Pune, Chennai, Ahmedabad and Hyderabad have reported seroprevalence ranging between 17.6 per cent and 56 per cent at different time points, the minister said.
18-plus beneficiaries may be vaccinated against Covid by Dec 2021: Centre
Asked if the government has decided to administer the COVID-19 vaccine to the entire population free of cost on priority basis and if so, the target fixed to administer the doses, the health minister said according to Revised Guidelines for Implementation of National COVID Vaccination Program, which came into effect from June 21, all citizens aged 18 years and above, irrespective of their income status, are entitled to free vaccination at all government vaccination centres.
COVID-19 vaccine: European medicines watchdog approves Moderna jab for ages 12 and up
The vaccine will be given in two injections, each four weeks apart. The decision by the Amsterdam-based agency follows the approval of the first vaccine for European youngsters, by Pfizer/BioNTech in May. The effects of Spikevax have been studied among 3,732 children aged 12 to 17 years, the EMA said.
Doc-population ratio 1:854, assuming 80% availability of allopathic docs, 5.65 lakh AYUSH docs: Govt
New Delhi: There is one doctor for every 854 people in the country, assuming 80 per cent availability of registered allopathic doctors and 5.65 lakh AYUSH doctors, Lok Sabha was informed on Friday. In a written reply, Minister of State for Health Bharati Pravin...
3rd Covid wave may occur either due to mutations in virus or pool of susceptible population: Govt
”The (third) wave may occur either due to mutations in the virus or due to the available pool of susceptible population, which in turn is also dependent on various pharmaceutical and non-pharmaceutical interventions for management of the pandemic,” Union Health Minister Mansukh Mandaviya said.
India urges foreign governments to easing travel restrictions for Indians
To a question on when the World Health Organisation (WHO) is expected to recognise Covaxin vaccine, he said its producer Bharat Biotech Limited has submitted the request along with all necessary documentation to the global body earlier this month.
Bagchi also said that more than half of the member states of the European Union have recognised Covishield, the vaccine manufactured by Pune-based Serum Institute of India.